Skip to content
Screener

Haemonetics HAE Other Non-Current Assets

Other Non-Current Assets at other companies

TFX
TeleflexTFX
$120.31M+7.4%
Medtronic logo
MedtronicMDT
$4.15B+15.7%
LivaNova logo
LivaNovaLIVN
$18.31M+27.8%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$1.65M+176%
Cerus logo
CerusCERS
$11.2M-2.8%
ITG
Integer HoldingsITGR
$39.56M+68.3%

Other financials

Income statement

See full
Revenue$339.4M+5.6%
Gross profit$202.8M+5.5%
Operating income$57.5M+6.7%
Net income$33.0M-3.0%
EPS (diluted)$0.72+2.9%

Balance sheet

See full
Cash & equivalents$223.4M-23.7%
Total debt$1.2B-4.1%
Total equity$837.1M-5.1%
Total assets$2.4B-3.9%

Cash flow

See full
Operating cash flow$52.3M+201%
CapEx$7.9M+111%
Free cash flow$44.4M+226%

Valuation

See full
Market cap$3.87B+6.3%
Enterprise value$4.82B+5.4%
P/E25.7×-10.5×
P/S2.9×+0.2×

Profitability

See full
Gross margin59%+2.1pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin21.5%+7.5pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.4×0.0×
Current ratio3.1×+1.4×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Haemonetics’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:09 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000313143-26-000120
Line itemJune 27, 2026March 28, 2026
Intangible assets, less accumulated amortization of $374,828 as of June 27, 2026 and $363,763 as of March 28, 2026434,512447,655
Goodwill656,884656,368
Deferred tax asset9,4349,521
Other long-term assets149,960141,741
Total assets$2,365,400$2,395,925
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Notes payable and current maturities of long-term debt$4,956$5,015

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Haemonetics's other non-current assets?
Haemonetics (HAE) reported other non-current assets of $149.96M in Q2 2026.
How has Haemonetics's other non-current assets changed year-over-year?
Haemonetics's other non-current assets decreased by 23.6% year-over-year, from $196.29M to $149.96M.
What is the long-term trend for Haemonetics's other non-current assets?
Over 5 years (2021 to 2026), Haemonetics's other non-current assets has grown at a 14.9% compound annual growth rate (CAGR), from $70.88M to $141.74M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Haemonetics's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude